yohimbine has been researched along with Disease Models, Animal in 140 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (10.00) | 18.7374 |
| 1990's | 16 (11.43) | 18.2507 |
| 2000's | 45 (32.14) | 29.6817 |
| 2010's | 60 (42.86) | 24.3611 |
| 2020's | 5 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Altenbach, RJ; Brioni, JD; Carr, TL; Chandran, P; Cowart, MD; Esbenshade, TA; Honore, P; Hsieh, GC; Lewis, LG; Liu, H; Manelli, AM; Marsh, KC; Milicic, I; Miller, TR; Strakhova, MI; Vortherms, TA; Wakefield, BD; Wetter, JM; Witte, DG | 1 |
| Filipek, B; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pańczyk, K; Pękala, E; Rapacz, A; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D; Żesławska, E | 1 |
| Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Fujimoto, Y; Juri, T; Mori, T; Nishikawa, K; Suehiro, K | 1 |
| Cao, B; Ji, Y; Jin, T; Liu, X; Ma, B; Ma, K; Shi, W; Yang, J | 1 |
| Cui, E; Li, M; Sun, J; Yan, M; Zhang, H; Zhang, Y; Zhou, J; Zhu, X | 1 |
| Hayashi, K; Shimokawa, T; Yamagata, M; Yoneda, K | 1 |
| Aktumsek, A; Antoniolli, AR; Araújo, AAS; Araújo-Filho, HG; Brito, RG; Coutinho, HDM; Lucchesi, A; Menezes, IRA; Menezes, PP; Quintans, JSS; Quintans-Júnior, LJ; Santos, PL; Scotti, L; Scotti, MT; Siqueira-Lima, PS; Zengin, G | 1 |
| Belluzzi, JD; Leslie, FM; Malagon, AM; Yasuda, D; Yuan, M; Zaveri, NT | 1 |
| Gil, D; Hsia, E; Tian, M | 1 |
| Bohannon, JB; Cheng, K; Fulenwider, HD; Heilig, M; King, CE; Nelson, BS; Nennig, SE; Rice, KC; Schank, JR; Sequeira, MK | 1 |
| Miura, T; Nishinaka, T; Shimokawa, T; Takama, M; Terada, T; Tsutsui, H; Yamagata, M; Yukimura, T | 1 |
| Carr, BJ; Nguyen, CT; Stell, WK | 1 |
| Cheng, K; Chimberoff, SH; Fulenwider, HD; Harvey, BK; Heilig, M; Nelson, BS; Nennig, SE; Rice, KC; Richie, CT; Schank, JR; Sequeira, MK; Smith, BM | 1 |
| Edwards, S; Koob, GF; Park, PE; Schlosburg, JE; Schulteis, G; Vendruscolo, LF | 1 |
| Bukhari, IA; Dar, A | 1 |
| Hickey, L; Hughes, SW; Hulse, RP; Lumb, BM; Pickering, AE | 1 |
| Dickson, CT; Hughes, AM; Lu, L; Treit, D; Yeung, M | 1 |
| Aladeokin, AC; Eduviere, AT; Olugbemide, AS; Umukoro, S | 1 |
| Chauvet, C; Duranti, A; Lardeux, MV; Nicolas, C; Solinas, M; Thiriet, N | 1 |
| Doudet, DJ; Iversen, P; Jakobsen, S; Landau, AM; Lillethorup, TP; Phan, JA; Simonsen, M; Wegener, G | 1 |
| Brunori, G; Cippitelli, A; Gaiolini, KA; Toll, L; Zaveri, NT | 1 |
| Bannister, K; Dickenson, AH; Goncalves, L; Patel, R; Townson, L | 1 |
| Abbas, G; Bhatti, HA; Mahmood, W; Rauf, K; Zada, W; Zeeshan, S | 1 |
| Berquist, MD; Mooney-Leber, SM; Pehrson, AL; Porter, JH; Porter, NP; Prus, AJ | 1 |
| Marinelli, M; Wong, WC | 1 |
| Ball, KT; Hyacinthe, J; Jarsocrak, H; Lambert, J; Lockowitz, J; Schrock, J | 1 |
| Batisti, AP; Carlesso, MG; Donatello, N; dos Santos, AR; Emer, AA; Martins, DF; Mazzardo-Martins, L; Micke, GA; Piovezan, AP; Pizzolatti, MG; Venzke, D | 1 |
| Iwase, T; Jimbo, S; Kobayashi, T; Miyakawa, T; Ogon, I; Takebayashi, T; Tanimoto, K; Terashima, Y; Tohse, N; Yamashita, T | 1 |
| Bilbao, A; Eisenhardt, M; Leixner, S; Spanagel, R | 1 |
| Beitz, AJ; Kim, SJ; Kwon, SK; Lee, JH; Roh, DH; Yeo, JH; Yoon, SY | 1 |
| Chen, JH; Jin, SY; Lei, DX; Song, XR; Yu, GF; Zhang, WH; Zhou, SL | 1 |
| Kirby, LG; Li, C | 1 |
| Banerjee, T; Holden, JE; Jeong, Y; Wagner, M | 1 |
| Li, H; Lu, D; Lv, X; Tang, X; Wang, F; Wang, H; Wang, Y; Yang, D | 1 |
| De Vries, TJ; Pattij, T; Schetters, D; Schippers, MC | 1 |
| Nasehi, M; Norozpour, Y; Sabouri-Khanghah, V; Torabi-Nami, M; Zarrindast, MR | 1 |
| Gisquet-Verrier, P; Le Dorze, C | 1 |
| Coutinho, HD; de Albuquerque, TR; de Lacerda Neto, LJ; de Menezes, IR; de Oliveira, LR; de Souza, SD; Dos Santos, AT; Kerntopf, MR; Quintans-Júnior, LJ; Ramos, AG; Santos Sales, V; Wanderley, AG | 1 |
| Matsumoto, K; Oka, JI; Sasaki-Hamada, S; Suzuki, A; Ueda, Y | 1 |
| Hagiwara, S; Iwasaka, H; Noguchi, T; Takeshima, N | 1 |
| Hashimoto, M; Ono, H; Tanabe, M | 1 |
| Dhir, A; Kulkarni, SK | 1 |
| Andurkar, SV; Bhalla, S; Gulati, A; Matwyshyn, G; Zhang, Z | 1 |
| Holden, JE; Jeong, Y | 1 |
| Ma, G; Sagawa, M; Sakuma, T; Shimazaki, M; Ueda, Y; Wang, Z; Xu, J | 1 |
| Albayrak, F; Borekci, B; Cadirci, E; Halici, Z; Karaca, M; Kumtepe, Y; Polat, B; Suleyman, H | 1 |
| Ding, Z; Raffa, RB | 1 |
| Crespi, F | 1 |
| Adeyemi, OO; Akindele, AJ; Ogunleye, EA | 1 |
| Adams-Deutsch, T; Epstein, DH; Nair, SG; Shaham, Y | 1 |
| Doihara, H; Ito, H; Kawabata-Shoda, E; Kojima, R; Nozawa, K; Yokoyama, T | 1 |
| Pettersen, VL; Raimundo, JM; Sudo, RT; Trachez, MM; Zapata-Sudo, G | 1 |
| Back, SE; Banna, KM; Do, P; See, RE | 1 |
| Anker, JJ; Carroll, ME | 2 |
| Bortolatto, CF; Jesse, CR; Nogueira, CW; Wilhelm, EA | 1 |
| de Sousa, DP; de Sousa, FC; de Vasconcelos, SM; Fonteles, MM; Macedo, DS; Melo, FH; Moura, BA; Viana, GS | 1 |
| Chen, HS; He, X; Qu, F; Wang, Y; Wen, WW | 1 |
| Anker, JJ; Carroll, ME; Zlebnik, NE | 1 |
| Cui, CC; Feng, J; Xu, HL; Yi, LT; Zhan, X; Zhou, LP | 1 |
| Ejtemaeimehr, Sh; Fatemeh, A; Mohammadi, A; Naghizadeh, MM; Zangeneh, FZ | 1 |
| Akinyinka, AO; Aladeokin, AC; Umukoro, S | 1 |
| Braconi, S; Cannella, N; Ciccocioppo, R; Cippitelli, A; Demopulos, G; Gaitanaris, G; Heilig, M; Kallupi, M; Massi, M; Ruggeri, B; Somaini, L; Stopponi, S | 1 |
| Cowan, A; Hirsch, DD; Kim, J; Lisek, R; Rawls, SM; Raymondi, N; Rosenthal, A | 1 |
| Hernádi, I; Tóth, M; Uzsoki, B | 1 |
| Aozuka, Y; Morimoto, Y; Shibata, Y | 1 |
| Coimbra, NC; de Freitas, RL; de Oliveira, R; de Oliveira, RC; dos Reis Ferreira, CM; Felippotti, TT; Paschoalin-Maurin, T | 1 |
| Bartlett, SE; Holgate, JY; Kanholm, I; Mill, D; Richards, JK; Simms, JA | 1 |
| Li, JX; Winter, JC; Zhang, Y | 1 |
| Dong, R; Feng, X; Li, W; Liu, J; Wang, H; Xu, J; Yu, B; Zhang, F | 1 |
| Bartlett, SE; Bito-Onon, J; Haass-Koffler, CL; Li, R; Simms, JA | 1 |
| Micov, AM; Paranos, SLj; Stepanović-Petrović, RM; Tomić, MA | 1 |
| Muck-Šeler, D; Pivac, N; Švob Štrac, D | 1 |
| Bakalli, H; Cai, L; Rinaman, L | 1 |
| Henriksnäs, J; Jansson, L; Pettersson, U; Sandberg, M | 1 |
| Cidral-Filho, FJ; Martins, DF; Mazzardo-Martins, L; Santos, AR; Stramosk, J | 1 |
| Bertholomey, ML; Czachowski, CL; Verplaetse, TL | 1 |
| Datta, S; Mavanji, V | 1 |
| Goncharenko, NV; Pankrat'ev, DV; Talalaenko, AN | 1 |
| Ernsberger, P; Koletsky, RJ; Velliquette, RA | 1 |
| Adir, Y; Azzam, ZS; Comellas, A; Crespo, A; Dada, LA; Krivoy, N; Lecuona, E; Ridge, KM; Rutschman, DH; Sznajder, JI | 1 |
| Bantel, C; Childers, SR; Duflo, F; Eisenach, JC; Tobin, JR | 1 |
| Hwang, BG; Kim, JH; Kim, SK; Min, BI; Na, HS; Park, DS; Yoo, GY | 2 |
| Fukuda, Y; Hasue, F; Kuwaki, T; Shimoyama, M; Yamada, H | 1 |
| Aksu, F; Belzung, C; Yalcin, I | 1 |
| Maehara, K; Maruyama, Y; Oikawa, Y; Saito, T; Tamagawa, K; Yaoita, H | 1 |
| Bae, SJ; Hwang, BG; Kim, JH; Kim, SK; Min, BI; Na, HS; Park, DS; Park, JH | 1 |
| Fink, GD; Galligan, JJ; Pérez-Rivera, AA | 1 |
| Campanella, S; Dan, B; Hanak, C; Meyvaert, A; Pelc, I; Streel, E; Verbanck, P | 1 |
| Fülöp, K; Gyires, K; Rónai, AZ; Zádori, Z | 1 |
| Anunciado, RV; Horio, F; Imamura, T; Kobayashi, M; Namikawa, T; Niki, I; Teradaira, S | 1 |
| Epstein, DH; Ghitza, UE; Gray, SM; Rice, KC; Shaham, Y | 1 |
| Baek, YH; Choi, DY; Huh, JE; Lee, JD; Park, DS | 1 |
| Bruno, KJ; Hess, EJ | 1 |
| Abel, M; Beenken, B; Dorflinger, J; Erwin, RJ; Keedy, SK; Marlow-O'Connor, M | 1 |
| Dierssen, M; Estivill, X; Gallego, X; Gratacòs, M; Maldonado, R; Murtra, P; Sahún, I; Trullás, R | 1 |
| Alguacil, LF; Alonso, E; Deuel, TF; Díez-Fernández, C; Ezquerra, L; Garrido, E; Herradón, G; Pérez-García, C | 1 |
| Arnar, DO; Martins, JB; Xing, D | 1 |
| Rosenzweig-Lipson, S; Schechter, LE; Sukoff Rizzo, SJ | 1 |
| Ono, H; Takasu, K; Takeuchi, Y; Tanabe, M | 1 |
| Boskovic, B; Prostran, M; Stepanović-Petrovic, R; Tomić, M; Ugresic, N; Vuckovic, S | 1 |
| An, L; Li, YF; Liu, XM; Yu, NJ; Yuan, L; Zhang, YZ; Zhao, N | 1 |
| Burnham, WM; King, GA | 1 |
| Delorme, P | 2 |
| Devissaguet, M | 1 |
| Actis, H; Dellazuana, O; Duhault, J; Roman, F | 1 |
| Willner, P | 1 |
| Griez, E | 1 |
| Beleslin, DB; Jovanović-Mićić, D; Samardzić, R | 1 |
| Li, P; Smyth, DD | 1 |
| Dubech, N; Garcia-Villar, R; Martinolle, JP; Moré, J | 1 |
| Gallar, J; Liu, JH | 1 |
| Ando, K; Fujita, T; Shimosawa, T | 1 |
| Bremner, AD; Charney, DS; Grillon, CG; Krystal, JH; Morgan, CA; Nagy, LM; Southwick, SM | 1 |
| Montastruc, JL; Portolan, G; Senard, JM; Tran, MA; Verwaerde, P | 1 |
| Bonilla-Jaime, H; Retana-Marquez, S; Velazquez-Moctezuma, J | 1 |
| Brotchie, JM; Crossman, AR; Henry, B | 1 |
| Schwartz, M; Wheeler, LA; Yoles, E | 1 |
| Brotchie, JM; Crossman, AR; Fox, SH; Henry, B; Peggs, D | 1 |
| Brotchie, JM; Hill, MP | 1 |
| Garcia-Rill, E; Miyazato, H; Skinner, RD | 1 |
| Gordienko, DV; Krivobok, GK; Pankrat'ev, DV; Talalaenko, AN; Zinkovich, II | 1 |
| Arad, MA; Dehpour, AR; Namiranian, K; Samini, M | 1 |
| Campbell, AM; Diamond, DM; Park, CR | 1 |
| Duxon, MS; Jones, N; King, SM | 1 |
| Bagheri, H; Chollet, F; Damase-Michel, C; Guiraud-Chaumeil, B; Houin, G; Llau, ME; Montastruc, JL; Sénard, JM; Tavernier, G; Tran, MA | 1 |
| Garzón, J; Sánchez-Blázquez, P | 1 |
| Dement, WC; Guilleminault, C; Mignot, E; Nishino, S; Renaud, A | 1 |
| Allain, H; Bentué-Ferrer, D; Decombe, R; Reymann, JM; Schatz, C | 1 |
| Czuczwar, SJ; Löscher, W | 1 |
| Paul, SM; Wolkowitz, OM | 1 |
| Dollery, CT; Struthers, AD | 1 |
| Nesse, RM; Rainey, JM | 1 |
| Hashimoto, K; Hoffman, BB; Honda, K; Tsujimoto, G | 1 |
| Labrid, C | 1 |
| Gershon, S; Geyer, H; Sanghvi, I | 1 |
9 review(s) available for yohimbine and Disease Models, Animal
| Article | Year |
|---|---|
The neuropharmacology of relapse to food seeking: methodology, main findings, and comparison with relapse to drug seeking.
Topics: Animals; Behavior, Addictive; Behavior, Animal; Disease Models, Animal; Feeding and Eating Disorders; Feeding Behavior; Food Preferences; Humans; Neuropharmacology; Yohimbine | 2009 |
The validity of animal models of depression.
Topics: 5-Hydroxytryptophan; Amphetamine; Animals; Behavior, Animal; Circadian Rhythm; Depressive Disorder; Dihydroxyphenylalanine; Disease Models, Animal; Drug Synergism; Helplessness, Learned; Humans; Kindling, Neurologic; Motor Activity; Olfactory Bulb; Predatory Behavior; Rats; Reserpine; Self Stimulation; Social Isolation; Stress, Psychological; Yohimbine | 1984 |
Experimental models of anxiety. Problems and perspectives.
Topics: Animals; Anxiety Disorders; Carbon Dioxide; Child; Conditioning, Classical; Disease Models, Animal; Dogs; Epinephrine; Fear; Humans; Individuality; Infant; Infusions, Parenteral; Lactates; Male; Panic; Stress, Psychological; Yohimbine | 1984 |
Noradrenergic alterations in posttraumatic stress disorder.
Topics: Adrenergic alpha-Antagonists; Animals; Controlled Clinical Trials as Topic; Disease Models, Animal; Norepinephrine; Receptors, Adrenergic; Stress Disorders, Post-Traumatic; Synaptic Transmission; Yohimbine | 1997 |
Progress in understanding the pathophysiology of cerebral ischemia: the almitrine-raubasine approach.
Topics: Almitrine; Animals; Brain Ischemia; Disease Models, Animal; Drug Combinations; Humans; Secologanin Tryptamine Alkaloids; Yohimbine | 1990 |
Neural and molecular mechanisms in anxiety.
Topics: Adenosine; Animals; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Binding, Competitive; Carbolines; Clonidine; Disease Models, Animal; Forecasting; Haplorhini; Humans; Locus Coeruleus; Piperoxan; Rats; Receptors, Cell Surface; Receptors, GABA-A; Receptors, Purinergic; Research Design; Yohimbine | 1985 |
Central nervous system mechanisms in blood pressure control.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Catecholamines; Clonidine; Disease Models, Animal; Ganglia, Sympathetic; Half-Life; Hypothalamus; Models, Neurological; Naloxone; Neurons; Nitroprusside; Norepinephrine; Phenylethanolamine N-Methyltransferase; Pressoreceptors; Propranolol; Rats; Rats, Inbred SHR; Receptors, Opioid; Reflex; Splanchnic Nerves; Thiophenes; Yohimbine | 1985 |
Psychobiology of anxiety and anxiety disorders.
Topics: Animals; Anxiety; Anxiety Disorders; Blood Platelets; Caffeine; Carbolines; Carbon Dioxide; Cats; Disease Models, Animal; Epinephrine; Humans; Hyperventilation; Isoproterenol; Lactates; Lactic Acid; Norepinephrine; Panic; Phobic Disorders; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Research Design; Yohimbine | 1985 |
[Experimental models in cerebral ischemia: application to the study of duxil].
Topics: Almitrine; Animals; Brain Ischemia; Cats; Cerebral Arteries; Disease Models, Animal; Dogs; Drug Combinations; Gerbillinae; Humans; Piperazines; Rabbits; Rats; Yohimbine | 1988 |
131 other study(ies) available for yohimbine and Disease Models, Animal
| Article | Year |
|---|---|
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Carrageenan; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Humans; Hyperalgesia; Ligands; Mice; Molecular Structure; Pain; Peritonitis; Quinazolines; Rats; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Stereoisomerism; Structure-Activity Relationship | 2008 |
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship | 2017 |
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Participation of the descending noradrenergic inhibitory system in the anti-hyperalgesic effect of acetaminophen in a rat model of inflammation.
Topics: Acetaminophen; Animals; Carrageenan; Disease Models, Animal; Hyperalgesia; Inflammation; Locus Coeruleus; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Spinal Cord; Yohimbine | 2021 |
Effect of sympathetic sprouting on the excitability of dorsal root ganglion neurons and afferents in a rat model of neuropathic pain.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic Fibers; Animals; Disease Models, Animal; Evoked Potentials, Somatosensory; Ganglia, Spinal; Guanfacine; Male; Neuralgia; Neurons; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Sciatic Nerve; Spinal Cord Dorsal Horn; Spinal Nerves; Stereotaxic Techniques; Yohimbine | 2022 |
Dexmedetomidine attenuates sevoflurane‑induced neurocognitive impairment through α2‑adrenoceptors.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Caspase 3; Cognitive Dysfunction; Dexmedetomidine; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Morris Water Maze Test; Random Allocation; Sevoflurane; Superoxide Dismutase; Treatment Outcome; Yohimbine | 2021 |
Inhibition of α
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Blister; Disease Models, Animal; Disease Progression; Epidermolysis Bullosa; Fibrosis; Hydralazine; Male; Nephrectomy; Norepinephrine; Periodontal Diseases; Photosensitivity Disorders; Proteinuria; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Yohimbine | 2021 |
Anti-hyperalgesic effect of Lippia grata leaf essential oil complexed with β-cyclodextrin in a chronic musculoskeletal pain animal model: Complemented with a molecular docking and antioxidant screening.
Topics: Analgesics; Animals; Antioxidants; beta-Cyclodextrins; Chronic Pain; Disease Models, Animal; Hyperalgesia; Lippia; Male; Methysergide; Mice; Molecular Docking Simulation; Musculoskeletal Pain; Naloxone; Oils, Volatile; Plant Leaves; Proto-Oncogene Proteins c-fos; Spinal Cord Dorsal Horn; Yohimbine | 2017 |
The α3β4 nAChR partial agonist AT-1001 attenuates stress-induced reinstatement of nicotine seeking in a rat model of relapse and induces minimal withdrawal in dependent rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Cholinergic Agonists; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Extinction, Psychological; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Oligopeptides; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Stress, Psychological; Substance Withdrawal Syndrome; Tobacco Use Disorder; Yohimbine | 2017 |
Reduction in ultraviolet B light-induced erythema by oxymetazoline and brimonidine is mediated by different α-adrenoceptors.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Calcium; Disease Models, Animal; Erythema; HEK293 Cells; Humans; Male; Mice; Mice, Hairless; Oxymetazoline; Prazosin; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Rosacea; Ultraviolet Rays; Vasoconstriction; Yohimbine | 2018 |
The neurokinin-1 receptor mediates escalated alcohol intake induced by multiple drinking models.
Topics: Adrenergic alpha-2 Receptor Antagonists; Alcohol Deterrents; Alcohol Drinking; Alcohol-Related Disorders; Amygdala; Animals; Animals, Outbred Strains; Corpus Striatum; Disease Models, Animal; Gene Expression Regulation; Male; Neurokinin-1 Receptor Antagonists; Nucleus Accumbens; Piperidines; Rats, Wistar; Receptors, Neurokinin-1; Yohimbine | 2018 |
Inhibition of α2C-adrenoceptors ameliorates cisplatin-induced acute renal failure in rats.
Topics: Acridines; Acute Kidney Injury; Adrenergic alpha-2 Receptor Antagonists; Animals; Apoptosis; Chemokine CCL2; Cisplatin; Disease Models, Animal; Injections, Intraperitoneal; Kidney; Male; Norepinephrine; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Tumor Necrosis Factor-alpha; Yohimbine | 2018 |
Alpha
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Axial Length, Eye; Brimonidine Tartrate; Chickens; Clonidine; Disease Models, Animal; Guanfacine; Intravitreal Injections; Male; Myopia; Sensory Deprivation; Yohimbine | 2019 |
Escalated Alcohol Self-Administration and Sensitivity to Yohimbine-Induced Reinstatement in Alcohol Preferring Rats: Potential Role of Neurokinin-1 Receptors in the Amygdala.
Topics: Adrenergic alpha-2 Receptor Antagonists; Alcohol-Related Disorders; Animals; Central Amygdaloid Nucleus; Central Nervous System Depressants; Conditioning, Operant; Disease Models, Animal; Ethanol; Male; Neurokinin-1 Receptor Antagonists; Neurons; Proto-Oncogene Proteins c-fos; Rats, Wistar; Receptors, Neurokinin-1; Recurrence; Self Administration; Yohimbine | 2019 |
Corticotropin-releasing factor (CRF) and α 2 adrenergic receptors mediate heroin withdrawal-potentiated startle in rats.
Topics: Acoustic Stimulation; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Analysis of Variance; Animals; Clonidine; Conditioning, Operant; Corticotropin-Releasing Hormone; Disease Models, Animal; Heroin; Male; Narcotics; Norepinephrine; Psychoacoustics; Pyrimidines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Reflex, Startle; Self Administration; Substance Withdrawal Syndrome; Time Factors; Yohimbine | 2013 |
Behavioral profile of Hypericum perforatum (St. John's Wort) extract. A comparison with standard antidepressants in animal models of depression.
Topics: Animals; Antidepressive Agents; Depression; Disease Models, Animal; Hypericum; Male; Mice; Motor Activity; Pentylenetetrazole; Plant Extracts; Rats; Rats, Sprague-Dawley; Rats, Wistar; Yohimbine | 2013 |
Endogenous analgesic action of the pontospinal noradrenergic system spatially restricts and temporally delays the progression of neuropathic pain following tibial nerve injury.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Analysis of Variance; Animals; Disease Models, Animal; Dopamine beta-Hydroxylase; Electromyography; Functional Laterality; Hyperalgesia; Male; Neuralgia; Pain Measurement; Pain Threshold; Pons; Prazosin; Rats; Rats, Wistar; Spinal Cord; Tibial Neuropathy; Time Factors; Yohimbine | 2013 |
FG7142, yohimbine, and βCCE produce anxiogenic-like effects in the elevated plus-maze but do not affect brainstem activated hippocampal theta.
Topics: Adrenergic alpha-2 Receptor Antagonists; Analysis of Variance; Animals; Anxiety; Biophysics; Brain Stem; Carbolines; Disease Models, Animal; Electric Stimulation; GABA Antagonists; Hippocampus; Male; Maze Learning; Rats; Rats, Sprague-Dawley; Theta Rhythm; Yohimbine | 2013 |
Antidepressant-like property of Jobelyn®, an African unique herbal formulation, in mice.
Topics: Animals; Antidepressive Agents; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Hindlimb Suspension; Male; Medicine, African Traditional; Mice; Motor Activity; Plant Extracts; Swimming; Time Factors; Yohimbine | 2014 |
Chronic stimulation of the tone of endogenous anandamide reduces cue- and stress-induced relapse in rats.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Benzamides; Carbamates; Cocaine; Cocaine-Related Disorders; Cues; Disease Models, Animal; Dopamine Uptake Inhibitors; Drug-Seeking Behavior; Endocannabinoids; Enzyme Inhibitors; Male; Polyunsaturated Alkamides; Rats, Sprague-Dawley; Recurrence; Self Administration; Stress, Physiological; Yohimbine | 2014 |
Decreased in vivo α2 adrenoceptor binding in the Flinders Sensitive Line rat model of depression.
Topics: Animals; Brain; Carbon Radioisotopes; Depressive Disorder; Disease Models, Animal; Female; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Yohimbine | 2015 |
Pharmacological stress is required for the anti-alcohol effect of the α3β4* nAChR partial agonist AT-1001.
Topics: Adrenergic alpha-2 Receptor Antagonists; Alcoholism; Animals; Central Nervous System Depressants; Conditioning, Operant; Cues; Disease Models, Animal; Drug Partial Agonism; Drug-Seeking Behavior; Ethanol; Male; Maze Learning; Nicotinic Agonists; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Reinforcement, Psychology; Self Administration; Yohimbine | 2015 |
Diffuse noxious inhibitory controls and nerve injury: restoring an imbalance between descending monoamine inhibitions and facilitations.
Topics: Action Potentials; Adrenergic alpha-2 Receptor Antagonists; Analysis of Variance; Animals; Biogenic Monoamines; Diffuse Noxious Inhibitory Control; Disease Models, Animal; Duloxetine Hydrochloride; Evoked Potentials; Male; Neurons; Ondansetron; Peripheral Nerve Injuries; Phenols; Rats; Rats, Sprague-Dawley; Recovery of Function; Serotonin and Noradrenaline Reuptake Inhibitors; Serotonin Antagonists; Tapentadol; Time Factors; Yohimbine | 2015 |
Cinnamomum cassia: an implication of serotonin reuptake inhibition in animal models of depression.
Topics: Animals; Antidepressive Agents; Cinnamomum aromaticum; Depression; Disease Models, Animal; Fluoxetine; Hindlimb Suspension; Male; Mice, Inbred BALB C; Motor Activity; Plant Bark; Plant Extracts; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Swimming; Yohimbine | 2016 |
The antidepressant drugs fluoxetine and duloxetine produce anxiolytic-like effects in a schedule-induced polydipsia paradigm in rats: enhancement of fluoxetine's effects by the α2 adrenoceptor antagonist yohimbine.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Anti-Anxiety Agents; Antidepressive Agents; Disease Models, Animal; Drinking; Drinking Water; Duloxetine Hydrochloride; Fluoxetine; Food Deprivation; Male; Polydipsia; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Yohimbine | 2015 |
Adolescent-onset of cocaine use is associated with heightened stress-induced reinstatement of cocaine seeking.
Topics: Age of Onset; Animals; Behavior, Animal; Cocaine; Cocaine-Related Disorders; Conditioning, Psychological; Corticosterone; Disease Models, Animal; Dopamine Uptake Inhibitors; Drug-Seeking Behavior; Electric Stimulation; Extinction, Psychological; Male; Rats; Rats, Sprague-Dawley; Recurrence; Reinforcement, Psychology; Stress, Psychological; Yohimbine | 2016 |
Yohimbine reinstates extinguished 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) seeking in rats with prior exposure to chronic yohimbine.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Behavior, Addictive; Benzazepines; Conditioning, Operant; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Extinction, Psychological; Feeding Behavior; Food; Hallucinogens; Male; N-Methyl-3,4-methylenedioxyamphetamine; Random Allocation; Rats, Sprague-Dawley; Self Administration; Stress, Psychological; Yohimbine | 2015 |
Inhalation of Cedrus atlantica essential oil alleviates pain behavior through activation of descending pain modulation pathways in a mouse model of postoperative pain.
Topics: Administration, Inhalation; Adrenergic alpha-2 Receptor Antagonists; alpha-Methyltyrosine; Analgesics; Animals; Behavior, Animal; Cedrus; Disease Models, Animal; Dopamine Antagonists; Fenclonine; Foot; Haloperidol; Hyperalgesia; Male; Mice; Motor Activity; Naloxone; Narcotic Antagonists; Oils, Volatile; Pain, Postoperative; Phytotherapy; Serotonin Antagonists; Yohimbine | 2015 |
Attenuation of pain behaviour by local administration of alpha-2 adrenoceptor antagonists to dorsal root ganglia in a rat radiculopathy model.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Behavior, Animal; Disease Models, Animal; Ganglia, Spinal; Indoles; Male; Neuralgia; Pain Measurement; Phentolamine; Prazosin; Radiculopathy; Rats; Rats, Sprague-Dawley; Yohimbine | 2016 |
Quantification of alcohol drinking patterns in mice.
Topics: Adrenergic alpha-2 Receptor Antagonists; Alcohol Drinking; Alcoholism; Animals; Automation, Laboratory; Behavioral Research; Central Nervous System Depressants; Circadian Rhythm; Disease Models, Animal; Equipment Design; Ethanol; Habituation, Psychophysiologic; Housing, Animal; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mutation; Period Circadian Proteins; Quinine; Stress, Psychological; Taste; Yohimbine | 2015 |
Repetitive Acupuncture Point Treatment with Diluted Bee Venom Relieves Mechanical Allodynia and Restores Intraepidermal Nerve Fiber Loss in Oxaliplatin-Induced Neuropathic Mice.
Topics: Acupuncture Points; Acupuncture Therapy; Adrenergic alpha-2 Receptor Antagonists; Analgesics; Animals; Bee Venoms; Disease Models, Animal; Epidermis; Foot; Hyperalgesia; Male; Mice, Inbred C57BL; Nerve Fibers; Organoplatinum Compounds; Oxaliplatin; Pain; Pain Threshold; Peripheral Nervous System Diseases; Random Allocation; Receptors, Adrenergic, alpha-2; Touch; Yohimbine | 2016 |
Activation of α2 adrenoceptor attenuates lipopolysaccharide-induced hepatic injury.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Chemical and Drug Induced Liver Injury; Cytoprotection; Dexmedetomidine; Disease Models, Animal; Interleukin-1beta; Interleukin-6; Lactic Acid; Lipopolysaccharides; Liver; Male; Malondialdehyde; Oxidative Stress; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Sepsis; Superoxide Dismutase; Time Factors; Tumor Necrosis Factor-alpha; Yohimbine | 2015 |
Effects of cocaine history on postsynaptic GABA receptors on dorsal raphe serotonin neurons in a stress-induced relapse model in rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics, Opioid; Animals; Cocaine; Cocaine-Related Disorders; Disease Models, Animal; Dopamine Uptake Inhibitors; Dorsal Raphe Nucleus; Extinction, Psychological; Inhibitory Postsynaptic Potentials; Male; Morphine; Patch-Clamp Techniques; Rats, Sprague-Dawley; Receptors, GABA; Self Administration; Serotonergic Neurons; Stress, Psychological; Tissue Culture Techniques; Yohimbine | 2016 |
Sex differences in hypothalamic-mediated tonic norepinephrine release for thermal hyperalgesia in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Cobalt; Constriction, Pathologic; Dioxanes; Disease Models, Animal; Female; Hot Temperature; Hyperalgesia; Hypothalamus; Male; Neuralgia; Nociceptive Pain; Norepinephrine; Random Allocation; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Sciatic Nerve; Sex Characteristics; Yohimbine | 2016 |
Berberine in combination with yohimbine attenuates sepsis-induced neutrophil tissue infiltration and multiorgan dysfunction partly via IL-10-mediated inhibition of CCR2 expression in neutrophils.
Topics: Animals; Antibodies, Blocking; Berberine; Cecum; Cell Movement; Cells, Cultured; Disease Models, Animal; Drug Therapy, Combination; Humans; Interleukin-10; Male; Mice; Mice, Inbred Strains; Multiple Organ Failure; Neutrophils; Receptors, CCR2; Sepsis; Yohimbine | 2016 |
Differential effects of the pharmacological stressor yohimbine on impulsive decision making and response inhibition.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Attention Deficit Disorder with Hyperactivity; Choice Behavior; Decision Making; Disease Models, Animal; Impulsive Behavior; Inhibition, Psychological; Male; Rats; Rats, Wistar; Reaction Time; Reward; Yohimbine | 2016 |
The effect of CA1 α2 adrenergic receptors on memory retention deficit induced by total sleep deprivation and the reversal of circadian rhythm in a rat model.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Behavior, Animal; CA1 Region, Hippocampal; Circadian Rhythm; Clonidine; Disease Models, Animal; Memory Consolidation; Memory Disorders; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Retention, Psychology; Sleep Deprivation; Yohimbine | 2016 |
Sensitivity to trauma-associated cues is restricted to vulnerable traumatized rats and reinstated after extinction by yohimbine.
Topics: Adrenergic alpha-2 Receptor Antagonists; Anhedonia; Animals; Anxiety; Arousal; Conditioning, Classical; Cues; Depression; Disease Models, Animal; Extinction, Psychological; Fear; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Resilience, Psychological; Stress Disorders, Post-Traumatic; Yohimbine | 2016 |
Gastroprotective and ulcer healing effects of hydroethanolic extract of leaves of Caryocar coriaceum: Mechanisms involved in the gastroprotective activity.
Topics: Animals; Antioxidants; Capsaicin; Chromatography, High Pressure Liquid; Chronic Disease; Disease Models, Animal; Ericales; Ethanol; Female; Flavonoids; Gastrointestinal Motility; Glyburide; Histamine; Indomethacin; Male; Mice; Mucus; Naloxone; NG-Nitroarginine Methyl Ester; Phenols; Phytotherapy; Plant Extracts; Plant Leaves; Protective Agents; Stomach Ulcer; Water; Yohimbine | 2017 |
Serotonergic and dopaminergic systems are implicated in antidepressant-like effects of chotosan, a Kampo formula, in mice.
Topics: Animals; Antidepressive Agents; Disease Models, Animal; Dopamine Agents; Drugs, Chinese Herbal; Fenclonine; Imipramine; Ketanserin; Locomotion; Male; Medicine, Kampo; Metergoline; Mice; Piperazines; Pyridines; Serotonin Agents; Sulpiride; Swimming; Yohimbine | 2017 |
Mechanisms of analgesic action of pulsed radiofrequency on adjuvant-induced pain in the rat: roles of descending adrenergic and serotonergic systems.
Topics: Adrenergic alpha-Antagonists; Analgesia; Animals; Brain Stem; Catecholamines; Catheter Ablation; Disease Models, Animal; Efferent Pathways; Freund's Adjuvant; Inflammation; Male; Neural Inhibition; Nociceptors; Pain; Pain Management; Rats; Rats, Sprague-Dawley; Sciatic Neuropathy; Serotonin; Serotonin Antagonists; Treatment Outcome; Tropanes; Yohimbine | 2009 |
Imidazoline I(1) receptor-mediated reduction of muscle rigidity in the reserpine-treated murine model of Parkinson's disease.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Benzazepines; Benzofurans; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Electromyography; Idazoxan; Imidazoles; Imidazoline Receptors; Injections, Intraperitoneal; Ligands; Male; Mice; Muscle Rigidity; Muscle, Skeletal; Parkinsonian Disorders; Reserpine; Time Factors; Yohimbine | 2008 |
Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: possible involvement of alpha-2 adrenergic receptors.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Cyclohexanols; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Immobility Response, Tonic; Locomotion; Male; Mice; Receptors, Adrenergic, alpha-2; Risperidone; Swimming; Venlafaxine Hydrochloride; Yohimbine | 2008 |
Determination of adrenergic and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by clonidine and BMS182874.
Topics: Adrenergic alpha-Agonists; Analgesics, Opioid; Animals; Area Under Curve; Clonidine; Dansyl Compounds; Disease Models, Animal; Drug Synergism; Idazoxan; Imidazoline Receptors; Male; Morphine; Oxycodone; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Time Factors; Yohimbine | 2009 |
Lateral hypothalamic-induced alpha-adrenoceptor modulation occurs in a model of inflammatory pain in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Carbachol; Cholinergic Agonists; Disease Models, Animal; Female; Hypothalamic Area, Lateral; Inflammation; Isothiocyanates; Nociceptors; Nursing Research; Pain; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Adrenergic, alpha; Tarsus, Animal; Yohimbine | 2009 |
Endogenous catecholamine stimulates alveolar fluid clearance in rats with acute pancreatitis.
Topics: Acute Disease; Adrenalectomy; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Bronchoalveolar Lavage Fluid; Catecholamines; Disease Models, Animal; Epinephrine; Epithelial Sodium Channels; Male; Pancreatitis; Prazosin; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; RNA, Messenger; Taurocholic Acid; Yohimbine | 2009 |
Role of alpha-2 adrenergic receptors in anti-ulcer effect mechanism of estrogen and luteinising hormone on rats.
Topics: Adrenergic alpha-Antagonists; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Drug Therapy, Combination; Estradiol; Estrogen Antagonists; Female; Indomethacin; Luteinizing Hormone; Ovariectomy; Rats; Receptors, Adrenergic, alpha-2; Tamoxifen; Ulcer; Yohimbine | 2009 |
Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphine.
Topics: Acetylcholine; Adrenergic alpha-Antagonists; Aminoquinolines; Analgesics, Opioid; Anesthetics, Local; Animals; Benzamides; Brain; Buprenorphine; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fentanyl; GTP-Binding Proteins; Injections, Intraventricular; Injections, Spinal; Male; Mice; Morphine; Naloxone; Narcotic Antagonists; Nociceptin; Nociceptin Receptor; Okadaic Acid; Oligonucleotides, Antisense; Opioid Peptides; Pain; Pain Measurement; Pain Threshold; Pertussis Toxin; Phosphoprotein Phosphatases; Piperazines; Pyridines; Receptor, Serotonin, 5-HT1A; Receptors, Opioid; Serotonin 5-HT1 Receptor Antagonists; Serotonin Antagonists; Signal Transduction; Yohimbine | 2009 |
Anxiolytics antagonize yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxiety.
Topics: Action Potentials; Adrenergic alpha-Antagonists; Amygdala; Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain; Buspirone; Chlordiazepoxide; Disease Models, Animal; Electrophysiology; Locus Coeruleus; Male; Neurons; Neuropharmacology; Neurophysiology; Norepinephrine; Rats; Receptors, Adrenergic, alpha-2; Yohimbine | 2009 |
Evaluation of the antidiarrhoeal effect of Sanseviera liberica Gerome & Labroy (Agavaceae) root extract.
Topics: Adrenergic alpha-Antagonists; Animals; Antidiarrheals; Castor Oil; Diarrhea; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gastrointestinal Transit; Intestines; Isosorbide Dinitrate; Male; Medicine, African Traditional; Mice; Morphine; Narcotics; Phytotherapy; Plant Extracts; Plant Roots; Plants, Medicinal; Rats; Sansevieria; Vasodilator Agents; Yohimbine | 2009 |
Characterization of two models of drug-induced constipation in mice and evaluation of mustard oil in these models.
Topics: Animals; Atropine; Clonidine; Constipation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Gastrointestinal Transit; Indoles; Loperamide; Male; Mice; Mice, Inbred Strains; Mustard Plant; Naloxone; Plant Oils; Transient Receptor Potential Channels; TRPA1 Cation Channel; Yohimbine | 2009 |
The synergistic interaction between morphine and maprotiline after intrathecal injection in rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Amitriptyline; Analgesics, Opioid; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Citalopram; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Injections, Spinal; Male; Maprotiline; Morphine; Naloxone; Narcotic Antagonists; Pain; Pain Measurement; Pain Threshold; Rats; Rats, Wistar; Reaction Time; Selective Serotonin Reuptake Inhibitors; Time Factors; Yohimbine | 2009 |
Yohimbine stress potentiates conditioned cue-induced reinstatement of heroin-seeking in rats.
Topics: Animals; Behavior, Addictive; Behavior, Animal; Conditioning, Operant; Cues; Disease Models, Animal; Extinction, Psychological; Heroin; Male; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Stress, Psychological; Yohimbine | 2010 |
Reinstatement of cocaine seeking induced by drugs, cues, and stress in adolescent and adult rats.
Topics: Age Factors; Amphetamine-Related Disorders; Animals; Behavior, Addictive; Behavior, Animal; Central Nervous System Stimulants; Cocaine; Conditioning, Operant; Cues; Disease Models, Animal; Extinction, Psychological; Infusions, Intravenous; Male; Photic Stimulation; Rats; Rats, Wistar; Recurrence; Self Administration; Stress, Psychological; Time Factors; Yohimbine | 2010 |
Evidence for the involvement of the serotonergic 5-HT2A/C and 5-HT3 receptors in the antidepressant-like effect caused by oral administration of bis selenide in mice.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Exploratory Behavior; Hindlimb Suspension; Immobility Response, Tonic; Male; Mice; Monoamine Oxidase; Organoselenium Compounds; Propranolol; Receptors, Serotonin, 5-HT2; Receptors, Serotonin, 5-HT3; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin 5-HT3 Receptor Agonists; Serotonin 5-HT3 Receptor Antagonists; Serotonin Agents; Sodium-Potassium-Chloride Symporters; Swimming; Time Factors; Yohimbine | 2010 |
Sex differences in the effects of allopregnanolone on yohimbine-induced reinstatement of cocaine seeking in rats.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Anesthetics; Animals; Behavior, Addictive; Behavior, Animal; Cocaine; Conditioning, Operant; Disease Models, Animal; Extinction, Psychological; Female; Male; Pregnanolone; Rats; Rats, Wistar; Secondary Prevention; Self Administration; Sex Factors; Yohimbine | 2010 |
Antidepressant-like effect of carvacrol (5-Isopropyl-2-methylphenol) in mice: involvement of dopaminergic system.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Antidepressive Agents; Behavior, Animal; Benzazepines; Cymenes; Depression; Disease Models, Animal; Dopamine; Dopamine D2 Receptor Antagonists; Fenclonine; Hindlimb Suspension; Male; Mice; Monoterpenes; Motor Activity; Prazosin; Receptors, Dopamine D2; Sulpiride; Swimming; Yohimbine | 2011 |
Chemical or surgical sympathectomy prevents mechanical hyperalgesia induced by intraplantar injection of bee venom in rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Bee Venoms; Disease Models, Animal; Foot; Guanethidine; Hyperalgesia; Male; Motor Activity; Norepinephrine; Oxidopamine; Pain Threshold; Phentolamine; Prazosin; Rats; Rats, Sprague-Dawley; Reaction Time; Sympathectomy; Sympatholytics; Time Factors; Yohimbine | 2010 |
Differential effects of allopregnanolone on the escalation of cocaine self-administration and sucrose intake in female rats.
Topics: Animals; Behavior, Addictive; Behavior, Animal; Cocaine; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Pregnanolone; Rats; Rats, Wistar; Self Administration; Sucrose; Yohimbine | 2010 |
Involvement of monoaminergic systems in the antidepressant-like effect of nobiletin.
Topics: Adrenergic Antagonists; Animals; Antidepressive Agents; Benzazepines; Cyproheptadine; Depression; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Flavones; Fluoxetine; Hindlimb Suspension; Male; Mice; Mice, Inbred ICR; Motor Activity; Piperazines; Prazosin; Propranolol; Pyridines; Serotonin Antagonists; Sulpiride; Swimming; Yohimbine | 2011 |
The role of opioid system and its interaction with sympathetic nervous system in the processing of polycystic ovary syndrome modeling in rat.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Clonidine; Disease Models, Animal; Estradiol; Female; Gonadal Steroid Hormones; Naltrexone; Narcotic Antagonists; Ovary; Polycystic Ovary Syndrome; Rats; Rats, Wistar; Receptors, Opioid; Sympathetic Nervous System; Yohimbine | 2011 |
Antidepressant activity of methyl jasmonate, a plant stress hormone in mice.
Topics: Acetates; Animals; Antidepressive Agents; Behavior, Animal; Cyclopentanes; Depression; Disease Models, Animal; Female; Hindlimb Suspension; Immobility Response, Tonic; Male; Mice; Motor Activity; Norepinephrine; Oxylipins; Plant Growth Regulators; Serotonin; Swimming; Yohimbine | 2011 |
Activation of nuclear PPARγ receptors by the antidiabetic agent pioglitazone suppresses alcohol drinking and relapse to alcohol seeking.
Topics: Adrenergic alpha-2 Receptor Antagonists; Alcohol Drinking; Alcohols; Analysis of Variance; Anilides; Animals; Behavior, Animal; Blood Glucose; Conditioning, Operant; Cues; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Food Preferences; Gene Expression Regulation; Hypoglycemic Agents; Male; Pioglitazone; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Self Administration; Substance Withdrawal Syndrome; Thiazolidinediones; Yohimbine | 2011 |
Icilin-evoked behavioral stimulation is attenuated by alpha₂-adrenoceptor activation.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Agmatine; Analysis of Variance; Animals; Behavior, Animal; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Head Movements; Male; Movement Disorders; Pyrimidinones; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Time Factors; Yohimbine | 2011 |
Novelty response of rats determines the effect of prefrontal alpha-2 adrenoceptor modulation on anxiety.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Anxiety; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Guanfacine; Imidazoles; Individuality; Isoindoles; Male; Maze Learning; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Yohimbine | 2011 |
[Effects of estrogen and keishibukuryogan on hot flash-like symptoms induced by yohimbine in ovariectomized rats].
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Body Temperature; Clonidine; Disease Models, Animal; Drugs, Chinese Herbal; Estradiol; Estrogens; Female; Hot Flashes; Humans; Menopause; Norepinephrine; Ovariectomy; Phytotherapy; Rats; Rats, Sprague-Dawley; Rectum; Skin Temperature; Tail; Yohimbine | 2011 |
Paradoxical effect of noradrenaline-mediated neurotransmission in the antinociceptive phenomenon that accompanies tonic-clonic seizures: role of locus coeruleus neurons and α(2)- and β-noradrenergic receptors.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Neurons; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Drug Interactions; Locus Coeruleus; Male; Microinjections; Norepinephrine; Pain Measurement; Pain Threshold; Pentylenetetrazole; Propranolol; Rats; Rats, Wistar; Reaction Time; Receptors, Adrenergic, alpha-2; Seizures; Synaptic Transmission; Yohimbine | 2011 |
Induction of multiple reinstatements of ethanol- and sucrose-seeking behavior in Long-Evans rats by the α-2 adrenoreceptor antagonist yohimbine.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Conditioning, Operant; Corticosterone; Disease Models, Animal; Ethanol; Male; Rats; Rats, Long-Evans; Recurrence; Reinforcement Schedule; Self Administration; Stress, Psychological; Sucrose; Yohimbine | 2011 |
Morphine-induced antinociception in the rat: supra-additive interactions with imidazoline I₂ receptor ligands.
Topics: Adrenergic alpha-2 Receptor Antagonists; Agmatine; Analgesics; Analgesics, Opioid; Animals; Benzofurans; Disease Models, Animal; Drug Synergism; Idazoxan; Imidazoles; Imidazoline Receptors; Ligands; Male; Morphine; Pain; Rats; Rats, Sprague-Dawley; Saline Solution, Hypertonic; Yohimbine | 2011 |
Effects of clonidine on bilateral pain behaviors and inflammatory response in rats under the state of neuropathic pain.
Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics; Analysis of Variance; Animals; Clonidine; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Functional Laterality; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hyperalgesia; Inflammation; Macrophage-1 Antigen; Male; Pain Threshold; Physical Stimulation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sciatica; Time Factors; Yohimbine | 2011 |
Mifepristone in the central nucleus of the amygdala reduces yohimbine stress-induced reinstatement of ethanol-seeking.
Topics: Alcohol-Induced Disorders, Nervous System; Alcoholism; Amygdala; Animals; Disease Models, Animal; Drug Interactions; Hormone Antagonists; Male; Mifepristone; Rats; Rats, Long-Evans; Secondary Prevention; Stress, Physiological; Yohimbine | 2012 |
The mechanisms of antihyperalgesic effect of topiramate in a rat model of inflammatory hyperalgesia.
Topics: Analgesics; Animals; Bicuculline; Carrageenan; Disease Models, Animal; Dose-Response Relationship, Drug; Fructose; Hyperalgesia; Inflammation; Male; Naloxone; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, GABA-A; Receptors, Opioid; Topiramate; Yohimbine | 2013 |
The involvement of noradrenergic mechanisms in the suppressive effects of diazepam on the hypothalamic-pituitary-adrenal axis activity in female rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Neurons; Adrenocorticotropic Hormone; alpha-Methyltyrosine; Analysis of Variance; Animals; Antihypertensive Agents; Clonidine; Corticosterone; Diazepam; Disease Models, Animal; Enzyme Inhibitors; Female; Hypnotics and Sedatives; Rats; Rats, Wistar; Reserpine; Yohimbine | 2012 |
Yohimbine anxiogenesis in the elevated plus maze is disrupted by bilaterally disconnecting the bed nucleus of the stria terminalis from the central nucleus of the amygdala.
Topics: Amygdala; Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Denervation; Disease Models, Animal; Excitatory Amino Acid Agonists; Ibotenic Acid; Male; Maze Learning; Neural Pathways; Phosphopyruvate Hydratase; Rats; Rats, Sprague-Dawley; Septal Nuclei; Video Recording; Yohimbine | 2012 |
The α2-adrenoceptor antagonist yohimbine normalizes increased islet blood flow in GK rats: a model of type 2 diabetes.
Topics: Adrenergic alpha-2 Receptor Antagonists; Anesthesia; Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Injections, Intravenous; Islets of Langerhans; Male; Pancreas; Rats; Rats, Inbred WF; Regional Blood Flow; Yohimbine | 2013 |
Ankle joint mobilization affects postoperative pain through peripheral and central adenosine A1 receptors.
Topics: Adenosine; Analysis of Variance; Animals; Ankle Joint; Caffeine; Clonidine; Disease Models, Animal; Fenclonine; Hyperalgesia; Male; Mice; Morphine; Pain, Postoperative; Receptor, Adenosine A1; Xanthines; Yohimbine | 2013 |
Alterations in ethanol seeking and self-administration following yohimbine in selectively bred alcohol-preferring (P) and high alcohol drinking (HAD-2) rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Ethanol; Extinction, Psychological; Male; Motivation; Rats; Self Administration; Yohimbine | 2013 |
Sleep-wake effects of yohimbine and atropine in rats with a clomipramine-based model of depression.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Aggression; Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Atropine; Brain; Brain Chemistry; Clomipramine; Depressive Disorder; Disease Models, Animal; Injections, Intraventricular; Male; Muscarinic Antagonists; Norepinephrine; Rats; Rats, Wistar; Reaction Time; Sleep Wake Disorders; Sleep, REM; Wakefulness; Yohimbine | 2002 |
Neurochemical characteristics of the ventromedial hypothalamus in mediating the antiaversive effects of anxiolytics in different models of anxiety.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Apomorphine; Avoidance Learning; Biguanides; Brain Chemistry; Chlordiazepoxide; Clonidine; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Droperidol; Drug Interactions; GABA Agents; GABA Antagonists; GABA Modulators; gamma-Aminobutyric Acid; Glutamic Acid; Male; Memantine; Mephenytoin; Microinjections; Pentylenetetrazole; Phentolamine; Picrotoxin; Piperazines; Propranolol; Pyrimidines; Rats; Serotonin; Sulpiride; Ventromedial Hypothalamic Nucleus; Yohimbine | 2003 |
The role of I(1)-imidazoline receptors and alpha(2)-adrenergic receptors in the modulation of glucose and lipid metabolism in the SHROB model of metabolic syndrome X.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Benzofurans; Blood Pressure; Disease Models, Animal; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Imidazoles; Imidazoline Receptors; Lipid Metabolism; Male; Metabolic Syndrome; Obesity; Oxazoles; Rats; Rats, Inbred SHR; Receptors, Adrenergic, alpha-2; Receptors, Drug; Rilmenidine; Yohimbine | 2003 |
Norepinephrine increases alveolar fluid reabsorption and Na,K-ATPase activity.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amiloride; Animals; Biological Transport; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Male; Norepinephrine; Octopamine; Ouabain; Phenylephrine; Prazosin; Propranolol; Pulmonary Alveoli; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase; Up-Regulation; Water-Electrolyte Balance; Yohimbine | 2004 |
Spinal nerve ligation increases alpha2-adrenergic receptor G-protein coupling in the spinal cord.
Topics: Adrenergic alpha-Agonists; Animals; Disease Models, Animal; GTP-Binding Proteins; Guanosine Triphosphate; Ligation; Male; Mechanoreceptors; Pain Threshold; Peripheral Nervous System Diseases; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Signal Transduction; Spinal Cord; Spinal Nerves; Yohimbine | 2005 |
Effects of alpha1- and alpha2-adrenoreceptor antagonists on cold allodynia in a rat tail model of neuropathic pain.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Cold Temperature; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Male; Nociceptors; Pain Threshold; Prazosin; Rats; Rats, Sprague-Dawley; Spinal Nerves; Tail; Yohimbine | 2005 |
Inhibitory actions of endothelin-1 on pain processing.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Analgesics, Non-Narcotic; Animals; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Injections, Intraventricular; Male; Mice; Mice, Inbred C57BL; Neural Inhibition; Neural Pathways; Oligopeptides; Pain; Pain Measurement; Pain Threshold; Peptides, Cyclic; Piperidines; Prazosin; Reaction Time; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Adrenergic, alpha-1; Yohimbine | 2004 |
Effects of desipramine and tramadol in a chronic mild stress model in mice are altered by yohimbine but not by pindolol.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Analgesics, Opioid; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Body Weight; Chronic Disease; Desipramine; Disease Models, Animal; Male; Mice; Mice, Inbred BALB C; Motor Activity; Pindolol; Stress, Physiological; Tramadol; Yohimbine | 2005 |
Alterations of alpha-adrenergic modulations of coronary microvascular tone in dogs with heart failure.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Flow Velocity; Cineangiography; Coronary Angiography; Coronary Circulation; Coronary Vessels; Disease Models, Animal; Dogs; Enzyme Inhibitors; Female; Heart Failure; Injections, Intra-Arterial; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Propranolol; Quinazolines; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Vascular Resistance; Vasodilation; Yohimbine | 2005 |
Effects of electroacupuncture on cold allodynia in a rat model of neuropathic pain: mediation by spinal adrenergic and serotonergic receptors.
Topics: Adrenergic alpha-Antagonists; Animals; Cold Temperature; Disease Models, Animal; Dose-Response Relationship, Radiation; Electroacupuncture; Hyperesthesia; Male; Pain Management; Pain Measurement; Prazosin; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Adrenergic; Receptors, Serotonin; Serotonin Antagonists; Spinal Cord; Time Factors; Yohimbine | 2005 |
Alpha-1B adrenoceptors mediate neurogenic constriction in mesenteric arteries of normotensive and DOCA-salt hypertensive mice.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Desoxycorticosterone; Disease Models, Animal; Dose-Response Relationship, Radiation; Drug Interactions; Electric Stimulation; Hypertension; In Vitro Techniques; Male; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Norepinephrine; Platelet Aggregation Inhibitors; Pyridoxal Phosphate; Receptors, Adrenergic, alpha-1; Vasoconstriction; Yohimbine | 2005 |
A pharmacological modulation of opiate withdrawal using an up-/down-regulation of the noradrenergic system in opiate-dependent rats.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Behavior, Animal; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Drug Interactions; Male; Morphine; Morphine Dependence; Narcotics; Norepinephrine; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Up-Regulation; Yohimbine | 2006 |
Individual differences in the sensitivity of cold allodynia to phentolamine in neuropathic rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Behavior, Animal; Cold Temperature; Disease Models, Animal; Hyperalgesia; Male; Nociceptors; Pain; Pain Threshold; Peripheral Nervous System Diseases; Phentolamine; Prazosin; Rats; Rats, Sprague-Dawley; Spinal Nerves; Time Factors; Yohimbine | 2005 |
Characterisation of alpha2-adrenoceptor subtypes involved in gastric emptying, gastric motility and gastric mucosal defence.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Gastric Emptying; Gastric Mucosa; Gastrointestinal Motility; Male; Muscle Contraction; Muscle, Smooth; Naloxone; Narcotic Antagonists; Oxymetazoline; Prazosin; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Stomach Ulcer; Yohimbine | 2005 |
The HND mouse, a nonobese model of type 2 diabetes mellitus with impaired insulin secretion.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Animals, Wild; Blood Glucose; Clonidine; Crosses, Genetic; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Epinephrine; Female; Glucose Tolerance Test; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Mice; Yohimbine | 2005 |
The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: a role of CRF1 receptors.
Topics: Adrenergic alpha-Antagonists; Animals; Anxiety; Behavior, Animal; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Extinction, Psychological; Food Preferences; Interpersonal Relations; Male; Pyrimidines; Pyrroles; Rats; Rats, Long-Evans; Receptors, Corticotropin-Releasing Hormone; Yohimbine | 2006 |
Antinociceptive effect and the mechanism of bee venom acupuncture (Apipuncture) on inflammatory pain in the rat model of collagen-induced arthritis: Mediation by alpha2-Adrenoceptors.
Topics: Acupuncture Points; Adrenergic alpha-Antagonists; Animals; Arthritis, Experimental; Bee Venoms; Behavior, Animal; Collagen; Disease Models, Animal; Drug Administration Routes; Drug Interactions; Male; Naloxone; Narcotic Antagonists; Pain; Pain Management; Pain Measurement; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Adrenergic, alpha-2; Statistics, Nonparametric; Yohimbine | 2006 |
The alpha(2C)-adrenergic receptor mediates hyperactivity of coloboma mice, a model of attention deficit hyperactivity disorder.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Attention Deficit Disorder with Hyperactivity; Basal Ganglia; Brain; Brain Chemistry; Catecholamines; Disease Models, Animal; Female; Genetic Predisposition to Disease; Hyperkinesis; Male; Mice; Mice, Neurologic Mutants; Motor Activity; Receptors, Adrenergic, alpha-2; Yohimbine | 2006 |
Noradrenergic antagonism of the P13 and N40 components of the rat auditory evoked potential.
Topics: Adrenergic alpha-Antagonists; Animals; Auditory Cortex; Auditory Pathways; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Evoked Potentials, Auditory; Geniculate Bodies; Hippocampus; Male; Nerve Net; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Schizophrenic Psychology; Signal Processing, Computer-Assisted; Synaptic Transmission; Yohimbine | 2007 |
Differential responses to anxiogenic drugs in a mouse model of panic disorder as revealed by Fos immunocytochemistry in specific areas of the fear circuitry.
Topics: Animals; Anxiety; Brain; Caffeine; Disease Models, Animal; Fear; Male; Mice; Mice, Transgenic; Oncogene Proteins v-fos; Panic Disorder; Random Allocation; Sodium Lactate; Yohimbine | 2007 |
Yohimbine prevents morphine-induced changes of glial fibrillary acidic protein in brainstem and alpha2-adrenoceptor gene expression in hippocampus.
Topics: Adrenergic alpha-Antagonists; Animals; Astrocytes; Autonomic Pathways; Biomarkers; Brain Stem; Disease Models, Animal; Down-Regulation; Gene Expression; Glial Fibrillary Acidic Protein; Hippocampus; Locus Coeruleus; Male; Morphine; Morphine Dependence; Narcotics; Neuronal Plasticity; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; RNA, Messenger; Solitary Nucleus; Up-Regulation; Yohimbine | 2007 |
Alpha-2 adrenergic antagonism enhances risk of ventricular tachycardia during acute ischemia.
Topics: Adrenergic alpha-Antagonists; Animals; Disease Models, Animal; Dogs; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Male; Myocardial Ischemia; Purkinje Fibers; Receptors, Adrenergic, alpha-2; Tachycardia, Ventricular; Yohimbine | 2007 |
A novel approach for predicting antidepressant-induced sexual dysfunction in rats.
Topics: Animals; Antidepressive Agents; Bupropion; Desipramine; Disease Models, Animal; Dopamine Agonists; Fluoxetine; Long-Term Care; Male; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Vasodilator Agents; Yohimbine | 2008 |
Pregabalin, S-(+)-3-isobutylgaba, activates the descending noradrenergic system to alleviate neuropathic pain in the mouse partial sciatic nerve ligation model.
Topics: Adrenergic Agents; Afferent Pathways; Analgesics; Animals; Behavior, Animal; Brain Stem; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; gamma-Aminobutyric Acid; Hyperalgesia; Locomotion; Male; Methoxyhydroxyphenylglycol; Mice; Norepinephrine; Oxidopamine; Pain Measurement; Pregabalin; Sciatic Neuropathy; Spinal Cord; Time Factors; Yohimbine | 2007 |
Role of alpha2-adrenoceptors in the local peripheral antinociception by carbamazepine in a rat model of inflammatory mechanical hyperalgesia.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Analgesics, Non-Narcotic; Animals; Carbamazepine; Concanavalin A; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Hindlimb; Hyperalgesia; Inflammation; Injections; Male; Pain; Pain Measurement; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Time Factors; Yohimbine | 2007 |
Role for serotonin in the antidepressant-like effect of a flavonoid extract of Xiaobuxin-Tang.
Topics: Animals; Antidepressive Agents; Apomorphine; Behavior, Animal; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Feeding Behavior; Fenclonine; Flavonoids; Humans; Hypothermia; Male; Mice; Mice, Inbred ICR; Motor Activity; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Serotonin; Stress, Physiological; Yohimbine | 2008 |
alpha 2-adrenergic antagonists suppress epileptiform EEG activity in a petit mal seizure model.
Topics: Adrenergic beta-Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy, Absence; Male; Mianserin; Piperoxan; Rats; Synaptic Transmission; Yohimbine | 1982 |
[Ultrastructural study of acute ischemia at the cerebral level. Effects of 5023 SE].
Topics: Acute Disease; Almitrine; Animals; Brain Ischemia; Disease Models, Animal; Drug Combinations; Microscopy, Electron; Piperazines; Rabbits; Telencephalon; Time Factors; Yohimbine | 1983 |
[Pharmacological approach to a treatment of senescence and cerebrovascular deficiencies related to hypoxia. Application to 5023 SE].
Topics: Aging; Almitrine; Animals; Cerebrovascular Circulation; Cerebrovascular Disorders; Disease Models, Animal; Dogs; Drug Combinations; Glucose; Humans; Hypoxia, Brain; Neurons; Oxygen Consumption; Piperazines; Rabbits; Rats; Yohimbine | 1983 |
[Effects of 5023 SE on experimental cerebral ischemia in gerbils].
Topics: Almitrine; Animals; Brain Ischemia; Disease Models, Animal; Drug Combinations; Gerbillinae; Piperazines; Time Factors; Yohimbine | 1983 |
[Ultrastructural study of acute ischemia at the peripheral level. Effects of 5023 SE].
Topics: Acute Disease; Almitrine; Animals; Brain Ischemia; Carotid Arteries; Disease Models, Animal; Drug Combinations; Endothelium; Microscopy, Electron; Piperazines; Rabbits; Yohimbine | 1983 |
The role of alpha-adrenergic mechanisms within the area postrema in dopamine-induced emesis.
Topics: Adrenergic alpha-Antagonists; alpha-Methyltyrosine; Animals; Atropine; Cats; Cerebral Ventricles; Dioxanes; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Hemicholinium 3; Idazoxan; Injections, Intraventricular; Male; Mecamylamine; Methyltyrosines; Methysergide; Naloxone; Oxidopamine; Prazosin; Reserpine; Tolazoline; Tyrosine 3-Monooxygenase; Vomiting; Yohimbine | 1995 |
Suppressed renal response to 2,6-dimethyl clonidine but not clonidine in one kidney-one clip hypertensive rats.
Topics: Adrenergic alpha-Agonists; Animals; Binding Sites; Clonidine; Dioxanes; Disease Models, Animal; Hypertension, Renovascular; Idazoxan; Kidney; Male; Natriuresis; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Drug; Tritium; Yohimbine | 1993 |
Inverse regulation of alpha- and beta-adrenoceptors during trinitrobenzenesulfonic acid (TNB)-induced inflammation in guinea-pig small intestine.
Topics: Animals; Dihydroalprenolol; Disease Models, Animal; Enteritis; Guinea Pigs; Intestinal Mucosa; Intestine, Small; Kinetics; Male; Membranes; Prazosin; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Trinitrobenzenesulfonic Acid; Tritium; Yohimbine | 1993 |
In vivo cAMP level in rabbit iris-ciliary body after topical epinephrine treatment.
Topics: Administration, Topical; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Aqueous Humor; Ciliary Body; Cyclic AMP; Dinoprostone; Disease Models, Animal; Drug Therapy, Combination; Epinephrine; Glaucoma; Intraocular Pressure; Iris; Laser Coagulation; Ophthalmic Solutions; Rabbits; Radioimmunoassay; Timolol; Yohimbine | 1996 |
Effect of insulin on norepinephrine overflow at peripheral sympathetic nerve endings in young spontaneously hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Buffers; Cocaine; Disease Models, Animal; Dopamine Uptake Inhibitors; Electric Stimulation; Enzyme Inhibitors; Hypertension; Insulin; Male; Nerve Endings; Norepinephrine; Ouabain; Potassium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium Chloride, Dietary; Sodium-Potassium-Exchanging ATPase; Sympathetic Nervous System; Yohimbine | 1996 |
Effects of yohimbine, an alpha 2-adrenoceptor antagonist, on experimental neurogenic orthostatic hypotension.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Cross-Over Studies; Denervation; Disease Models, Animal; Dogs; Double-Blind Method; Epinephrine; Heart Rate; Hypotension, Orthostatic; Injections, Intravenous; Male; Norepinephrine; Posture; Random Allocation; Receptors, Adrenergic, alpha-2; Sinus of Valsalva; Yohimbine | 1997 |
Pharmacological features of masculine sexual behavior in an animal model of depression.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Antagonists; Animals; Animals, Newborn; Clomipramine; Depression; Disease Models, Animal; Humans; Male; Muscarinic Agonists; Oxotremorine; Rats; Rats, Wistar; Serotonin Receptor Agonists; Sexual Behavior, Animal; Yohimbine | 1998 |
Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Behavior, Animal; Bromocriptine; Clonidine; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Levodopa; Lisuride; Locomotion; Male; Mazindol; Methoxydimethyltryptamines; Oxidopamine; Parkinson Disease, Secondary; Prosencephalon; Rats; Rats, Sprague-Dawley; Sympatholytics; Tritium; Yohimbine | 1998 |
Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration.
Topics: Action Potentials; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Axons; Brimonidine Tartrate; Cell Count; Cell Survival; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Nerve Degeneration; Neuroprotective Agents; Optic Nerve; Optic Nerve Diseases; Optic Nerve Injuries; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Retinal Ganglion Cells; Timolol; Yohimbine | 1999 |
The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Antagonists; Animals; Antiparkinson Agents; Brain; Callithrix; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Drug Synergism; Dyskinesias; Female; Idazoxan; Levodopa; Male; Receptors, Adrenergic, alpha-2; Time Factors; Yohimbine | 1999 |
The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective kappa-opioid receptor agonist, enadoline, in the monoamine-depleted rat.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Benzofurans; Biogenic Monoamines; Clonidine; Disease Models, Animal; Drug Combinations; Drug Synergism; Locomotion; Male; Naltrexone; Narcotic Antagonists; Parkinson Disease, Secondary; Prazosin; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reserpine; Yohimbine | 1999 |
Locus coeruleus involvement in the effects of immobilization stress on the p13 midlatency auditory evoked potential in the rat.
Topics: Adrenergic alpha-Antagonists; Animals; Corticotropin-Releasing Hormone; Disease Models, Animal; Dose-Response Relationship, Drug; Evoked Potentials, Auditory; Locus Coeruleus; Male; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Restraint, Physical; Stress Disorders, Post-Traumatic; Stress, Psychological; Yohimbine | 2000 |
The role of neurochemical mechanisms of ventromedial hypothalamus in various models of anxiety in rats.
Topics: Adrenergic Agents; Animals; Anxiety; Apomorphine; Avoidance Learning; Disease Models, Animal; Dopamine; Dopamine Agents; GABA Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Hypothalamus, Middle; Male; Memantine; Microinjections; Neurotransmitter Agents; Phenylephrine; Picrotoxin; Rats; Serotonin; Sulpiride; Yohimbine | 2001 |
Clonidine attenuates naloxone-induced opioid-withdrawal syndrome in cholestatic mice.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Cholestasis; Clonidine; Disease Models, Animal; Male; Mice; Naloxone; Narcotic Antagonists; Opioid Peptides; Substance Withdrawal Syndrome; Yohimbine | 2001 |
Chronic psychosocial stress impairs learning and memory and increases sensitivity to yohimbine in adult rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Anxiety Disorders; Behavior, Animal; Chronic Disease; Disease Models, Animal; Exploratory Behavior; Habituation, Psychophysiologic; Male; Maze Learning; Memory; Rats; Rats, Sprague-Dawley; Stress, Psychological; Yohimbine | 2001 |
Ethopharmacological analysis of the unstable elevated exposed plus maze, a novel model of extreme anxiety: predictive validity and sensitivity to anxiogenic agents.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Anxiety; Behavior, Animal; Caffeine; Carbolines; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Escape Reaction; Evaluation Studies as Topic; GABA Antagonists; Male; Maze Learning; Pentylenetetrazole; Piperazines; Rats; Reaction Time; Serotonin Receptor Agonists; Yohimbine | 2002 |
[Is there any desensitization of presynaptic alpha 2-adrenergic receptors in hypertension? Experimental and clinical studies].
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Animals; Denervation; Disease Models, Animal; Dogs; Humans; Hypertension; Middle Aged; Yohimbine | 1992 |
alpha N-acetyl human beta-endorphin-(1-31) alleviates the morphine withdrawal syndrome in rodents: a comparative study with clonidine.
Topics: Animals; beta-Endorphin; Clonidine; Disease Models, Animal; Male; Mice; Morphine; Naloxone; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Yohimbine | 1992 |
Effects of SDZ NVI-085, a putative subtype-selective alpha 1-agonist, on canine cataplexy, a disorder of rapid eye movement sleep.
Topics: Adrenergic alpha-Agonists; Animals; Blood Pressure; Body Temperature; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Cataplexy; Disease Models, Animal; Dogs; Eating; Heart Rate; Narcolepsy; Oxazines; Play and Playthings; Prazosin; Radioligand Assay; Yohimbine | 1991 |
Comparison of drugs with different selectivity for central alpha 1-and alpha 2-adrenoceptors in animal models of epilepsy.
Topics: Animals; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; Epilepsy; Female; Gerbillinae; Kindling, Neurologic; Male; Mice; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Species Specificity; Yohimbine | 1987 |
Desensitization of postjunctional alpha 1- and alpha 2-adrenergic receptor-mediated vasopressor responses in rat harboring pheochromocytoma.
Topics: Angiotensins; Animals; Blood Pressure; Cell Membrane; Disease Models, Animal; Dopamine; Heart Rate; Male; Mesenteric Arteries; Neoplasm Transplantation; Norepinephrine; Phentolamine; Pheochromocytoma; Prazosin; Propranolol; Rats; Receptors, Adrenergic, alpha; Vasoconstriction; Yohimbine | 1987 |
Exploration of the anti-depressant potential of lithium.
Topics: Animals; Antidepressive Agents; Autonomic Nervous System; Behavior, Animal; Bipolar Disorder; Blood Pressure; Disease Models, Animal; Dogs; Drug Synergism; Female; Humans; Imipramine; Lithium; Male; Yohimbine | 1973 |